Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease

Aim: Myostatin (Mstn) has been described as a trigger for the progression of atherosclerosis. In this study, we evaluated the role of Mstn in arterial remodeling in patients with end-stage renal disease (ESRD). Methods: Vascular specimens were collected from 16 ESRD patients (56.4 ± 7.9 years) under...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Atheroscler Thromb
Prif Awduron: Esposito, Pasquale, Verzola, Daniela, La Porta, Edoardo, Milanesi, Samantha, Grignano, Maria Antonietta, Avella, Alessandro, Gregorini, Marilena, Abelli, Massimo, Ticozzelli, Elena, Rampino, Teresa, Garibotto, Giacomo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Japan Atherosclerosis Society 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7585912/
https://ncbi.nlm.nih.gov/pubmed/32173683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.51144
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg